“Ollie’s Downgraded to Hold by Loop Capital Over Valuation Worries”
Loop Capital downgrades Ollie's Bargain Outlet from "Buy" to "Hold", attributing the decision to stock's limited upside following a recent surge. Despite the downgrade, the firm still recognizes Ollie's strong position in the disrupted retail sector, and anticipates a better entry point before resuming a bullish stance. Read more
Read More
“Datroway: AstraZeneca’s FDA-Approved Lung Cancer Treatment”
AstraZeneca and Daiichi Sankyo secure FDA approval for Datroway, achieving a crucial milestone in cancer treatment. Approved for advanced non-small cell lung cancer, Datroway is the first U.S. drug to go beyond breast cancer, offering hope to patients with TROP2-expressing tumors, and expanding the arsenal in the ongoing fight against cancer. Read more
Read More
“FactSet Q3 Earnings Miss Amid Strong Revenue Growth, Stable Outlook”
"Q3 fiscal results for FactSet Research Systems exceeded revenue expectations, demonstrating resilience in a challenging financial industry. Its wealth management and institutional buy-side segments performed particularly strongly, contributing to overall business growth. The company's management remains optimistic about future prospects, reinforcing FactSet's potential for sustained growth." Read more
Read More